Telomerase Reverse Transcriptase Subunit Expression Is Associated with Chondrosarcoma Malignancy
- 1 September 2004
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health)
- Vol. 426 (426), 117-124
- https://doi.org/10.1097/01.blo.0000141647.22689.de
Abstract
Expression of the telomerase reverse transcriptase subunit telomerase reverse transcriptase gene is associated with most human malignancies. Because telomerase reverse transcriptase is rarely expressed in normal tissue, its presence in pathologic specimens is considered a marker of transformed cells. Moreover, high levels of expression have been correlated with poor prognosis in many cancers. Although telomerase activity has been found in chondrosarcomas, its prognostic significance in these malignant cartilage tumors is unknown. Malignancy in cartilage-derived tumors is assessed routinely by histomorphologic grading, but even well differentiated, low-grade lesions can metastasize. This unpredictable behavior greatly complicates the clinical treatment of cartilage tumors, making better prognostic indicators desirable. To address this issue we used immunohistochemistry to compare telomerase reverse transcriptase expression in a collection of 61 tumors consisting of malignant chondrosarcomas of varying grade and benign enchondromas. Associated case histories were reviewed to test the hypothesis that telomerase reverse transcriptase expression levels correlated with subsequent tumor recurrence. We found that the relative abundance of telomerase reverse transcriptase-expressing cells correlated significantly with grade and recurrence. These findings indicate that telomerase reverse transcriptase immunostaining may be a useful adjunct to the conventional three-level grading system.Keywords
This publication has 27 references indexed in Scilit:
- The Nucleolar Localization Domain of the Catalytic Subunit of Human TelomeraseJournal of Biological Chemistry, 2002
- Molecular profiling of human chondrosarcomas for matrix production and cancer markersInternational Journal of Cancer, 2002
- Prognostic relevance of cell biologic and biochemical features in conventional chondrosarcomasCancer, 2002
- Telomerase is not an oncogeneOncogene, 2002
- Chondrosarcoma of BonePublished by Ovid Technologies (Wolters Kluwer Health) ,2001
- Alternative lengthening of telomeres is associated with chromosomal instability in osteosarcomasOncogene, 2001
- Extraskeletal Myxoid Chondrosarcoma: A Clinicopathologic, Immunohistochemical, and Ploidy Analysis of 23 CasesLaboratory Investigation, 2000
- Telomerase is Not an Epidermal Stem Cell Marker and is Downregulated by CalciumJournal of Investigative Dermatology, 1998
- Specific Association of Human Telomerase Activity with Immortal Cells and CancerScience, 1994
- A New Histologic Approach to the Differentiation of Enchondroma and Chondrosarcoma of the BonesPublished by Ovid Technologies (Wolters Kluwer Health) ,1985